Amyotrophic lateral sclerosis - Electrophysiologic aspects of its pathophysiology and new therapeutic options

Brain and Nerve

Volumn 62, Issue 8, 2010, Pages 885-891

  Kuwabara, Satoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Fasciculation; Potassium channel; Sodium channel; Split hand

Indexed keywords

POTASSIUM CHANNEL; SODIUM CHANNEL;

AMYOTROPHIC LATERAL SCLEROSIS; CELL DEATH; ELECTROPHYSIOLOGY; ENVIRONMENTAL FACTOR; EXCITOTOXICITY; FASCICULATION; HUMAN; MOTONEURON; MOTOR UNIT; NERVE ENDING; NERVE EXCITABILITY; NERVE FIBER TRANSPORT; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POTASSIUM CURRENT; REVIEW; SODIUM CURRENT; NERVE FIBER; PATHOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

AMYOTROPHIC LATERAL SCLEROSIS; AXONS; CELL DEATH; ELECTROPHYSIOLOGICAL PHENOMENA; HUMANS; MOTOR NEURONS; MUSCLE, SKELETAL; POTASSIUM CHANNELS; SODIUM CHANNELS;

EID: 77955834062     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Rothstein JD: Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 65 (Suppl 1):S3-S9, 2009
2. Bostock H, Cikurel K, Burke D: Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 21: 137-158, 1998
3. Eisen A: Clinical electrophysiology of the upper and lower motor neuron in amyotrophic lateral sclerosis. Semin Neurol 21: 141-154, 2001
4. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62, 1993
5. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, et al: TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351: 602-611, 2006
6. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, et al: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130-133, 2006
7. Layzer RB: The origin of muscle fasciculations and cramps. Muscle Nerve 17: 1243-1249, 1994
8. Newsom-Davis J: Autoimmune neuromyotonia (Isaacs' syndrome): an antibody-mediated potassium channelopathy. Ann N Y Acad Sci 835: 111-119, 1997
9. Kiernan MC, Guglielmi JM, Kaji R, Murray NM, Bostock H: Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 125: 664-675, 2002
10. Kiernan MC, Burke D, Andersen KV, Bostock H: Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 23: 399-409, 2000
11. Bostock H, Rothwell JC: Latent addition in motor and sensory fibres of human peripheral nerve. J Physiol 498: 277-294, 1997
12. Brain Nerve 59: 1109-1115, 2007
13. Mogyoros I, Kiernan MC, Burke D, Bostock H: Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis. Brain 121: 851-859, 1998
14. Priori A, Cinnante C, Pesenti A, Carpo M, Cappellari A, et al: Distinctive abnormalities of motor axonal strength-duration properties in multifocal motor neuropathy and in motor neurone disease. Brain 125: 2481-2490, 2002
15. Kanai K, Kuwabara S, Arai K, Sung JY, Ogawara K: Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment. Brain 126: 965-973, 2003
16. Kanai K, Kuwabara S, Misawa S, Tamura N, Ogawara K, et al: Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 129: 953-962, 2006
17. Vucic S, Kiernan MC: Axonal excitability properties in amyotrophic lateral sclerosis. Clin Neurophysiol 117: 1458-1466, 2006
18. + currents in human neuropathy and motor neuron disease estimated by latent addition. Clin Neurophysiol 117: 2451-2458, 2006
19. Kuwabara S, Misawa S: Axonal ionic pathophysiology in human peripheral neuropathy and motor neuron disease. Curr Neurovascular Res 4: 373-379, 2004
20. Devor M, Govrin-Lippmann R, Angelides K: Na+ channel immunolocalization in peripheral mammalian axons and changes following nerve injury and neuroma formation. J Neurosci 13: 1976-1992, 1993
21. Bostock H, Sharief MK, Reid G, Murray NM: Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain 118: 217-225, 1995
22. Eisen A, Kim S, Pant B: Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron? Muscle Nerve 15: 219-224, 1992
23. Kuwabara S, Mizobuchi K, Ogawara K, Hattori T: Dissociated small hand muscle involvement in amyotrophic lateral sclerosis detected by motor unit number estimates. Muscle Nerve 22: 870-873, 1999
24. Wilbourn AJ: The "split hand syndrome". Muscle Nerve 23: 138, 2000
25. Kuwabara S, Sonoo M, Komori T, Shimizu T, Hirashima F, et al: Dissociated small hand muscle atrophy in amyotrophic lateral sclerosis: frequency, extent, and specificity. Muscle Nerve 37: 426-430, 2008
26. Bae JS, Sawai S, Misawa S, Kanai K, Isose S, et al: Differences in excitability properties of FDI and ADM motor axons. Muscle Nerve 39: 350-354, 2009
27. Carrì MT, Grignaschi G, Bendotti C: Targets in ALS: designing multidrug therapies. Trends Pharmacol Sci 27: 267-273, 2006
28. Van Damme P, Dewil M, Robberecht W, Van Den Bosch L: Excitotoxicity and amyotrophic lateral sclerosis. Neurodegener Dis 2: 147-159, 2005
29. Boillée S, Vande Velde C, Cleveland DW: ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52: 39-59, 2006
30. Kriz J, Gowing G, Julien JP: Efficient three-drug cocktail for disease induced by mutant superoxide dismutase. Ann Neurol 53: 429-436, 2003